NanJing Pharmaceutical Company Limited (600713.SS)
CNY 5.2
(-0.38%)
CNY 5.2
(-0.38%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 28.5 Billion CNY | -9.92% |
| 2022 | 31.65 Billion CNY | 22.27% |
| 2021 | 25.88 Billion CNY | 10.58% |
| 2020 | 23.4 Billion CNY | 6.57% |
| 2019 | 21.96 Billion CNY | 12.33% |
| 2018 | 19.55 Billion CNY | 22.79% |
| 2017 | 15.92 Billion CNY | 14.06% |
| 2016 | 13.96 Billion CNY | 10.85% |
| 2015 | 12.59 Billion CNY | 10.85% |
| 2014 | 11.36 Billion CNY | 17.75% |
| 2013 | 9.64 Billion CNY | 4.58% |
| 2012 | 9.22 Billion CNY | 2.24% |
| 2011 | 9.02 Billion CNY | 7.77% |
| 2010 | 8.37 Billion CNY | 28.48% |
| 2009 | 6.51 Billion CNY | 29.22% |
| 2008 | 5.04 Billion CNY | 0.89% |
| 2007 | 4.99 Billion CNY | 35.58% |
| 2006 | 3.68 Billion CNY | 10.77% |
| 2005 | 3.32 Billion CNY | 6.21% |
| 2004 | 3.13 Billion CNY | 19.17% |
| 2003 | 2.62 Billion CNY | 44.8% |
| 2002 | 1.81 Billion CNY | 55.24% |
| 2001 | 1.16 Billion CNY | -4.82% |
| 2000 | 1.22 Billion CNY | 29.92% |
| 1999 | 946.17 Million CNY | 9.1% |
| 1998 | 867.23 Million CNY | 88.22% |
| 1997 | 460.74 Million CNY | 5.89% |
| 1996 | 435.11 Million CNY | 59.9% |
| 1995 | 272.11 Million CNY | 3.22% |
| 1994 | 263.64 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 32.56 Billion CNY | 14.22% |
| 2024 Q2 | 31.65 Billion CNY | -2.79% |
| 2024 Q3 | 32.45 Billion CNY | 2.52% |
| 2023 Q1 | 32.85 Billion CNY | 3.81% |
| 2023 Q4 | 28.5 Billion CNY | -14.13% |
| 2023 Q3 | 33.2 Billion CNY | -0.51% |
| 2023 Q2 | 33.37 Billion CNY | 1.56% |
| 2023 FY | 28.5 Billion CNY | -9.92% |
| 2022 Q3 | 31.11 Billion CNY | 12.17% |
| 2022 Q1 | 28.09 Billion CNY | 8.54% |
| 2022 FY | 31.65 Billion CNY | 22.27% |
| 2022 Q4 | 31.65 Billion CNY | 1.72% |
| 2022 Q2 | 27.73 Billion CNY | -1.27% |
| 2021 Q2 | 25.45 Billion CNY | -0.94% |
| 2021 Q1 | 25.69 Billion CNY | 9.75% |
| 2021 FY | 25.88 Billion CNY | 10.58% |
| 2021 Q4 | 25.88 Billion CNY | -3.55% |
| 2021 Q3 | 26.83 Billion CNY | 5.46% |
| 2020 FY | 23.4 Billion CNY | 6.57% |
| 2020 Q1 | 24.26 Billion CNY | 10.47% |
| 2020 Q2 | 21.45 Billion CNY | -11.6% |
| 2020 Q3 | 22.86 Billion CNY | 6.61% |
| 2020 Q4 | 23.4 Billion CNY | 2.37% |
| 2019 Q2 | 22.02 Billion CNY | -0.27% |
| 2019 Q4 | 21.96 Billion CNY | -7.73% |
| 2019 Q3 | 23.8 Billion CNY | 8.09% |
| 2019 Q1 | 22.08 Billion CNY | 12.93% |
| 2019 FY | 21.96 Billion CNY | 12.33% |
| 2018 Q3 | 19.39 Billion CNY | 7.52% |
| 2018 FY | 19.55 Billion CNY | 22.79% |
| 2018 Q4 | 19.55 Billion CNY | 0.82% |
| 2018 Q2 | 18.03 Billion CNY | -0.15% |
| 2018 Q1 | 18.06 Billion CNY | 13.45% |
| 2017 Q4 | 15.92 Billion CNY | -2.69% |
| 2017 FY | 15.92 Billion CNY | 14.06% |
| 2017 Q3 | 16.36 Billion CNY | 11.06% |
| 2017 Q2 | 14.73 Billion CNY | -1.97% |
| 2017 Q1 | 15.03 Billion CNY | 7.66% |
| 2016 Q1 | 13.7 Billion CNY | 8.85% |
| 2016 Q3 | 14.92 Billion CNY | 10.85% |
| 2016 FY | 13.96 Billion CNY | 10.85% |
| 2016 Q2 | 13.46 Billion CNY | -1.8% |
| 2016 Q4 | 13.96 Billion CNY | -6.44% |
| 2015 Q2 | 12.51 Billion CNY | 4.21% |
| 2015 Q1 | 12 Billion CNY | 5.69% |
| 2015 Q3 | 13.21 Billion CNY | 5.58% |
| 2015 Q4 | 12.59 Billion CNY | -4.68% |
| 2015 FY | 12.59 Billion CNY | 10.85% |
| 2014 FY | 11.36 Billion CNY | 17.75% |
| 2014 Q1 | 10.47 Billion CNY | 8.57% |
| 2014 Q2 | 10.27 Billion CNY | -1.96% |
| 2014 Q3 | 11.25 Billion CNY | 9.62% |
| 2014 Q4 | 11.36 Billion CNY | 0.92% |
| 2013 Q1 | 9.53 Billion CNY | 3.35% |
| 2013 Q2 | 9.48 Billion CNY | -0.59% |
| 2013 Q3 | 10.31 Billion CNY | 8.86% |
| 2013 Q4 | 9.64 Billion CNY | -6.49% |
| 2013 FY | 9.64 Billion CNY | 4.58% |
| 2012 Q2 | 10.36 Billion CNY | 5.41% |
| 2012 Q3 | 10.56 Billion CNY | 1.91% |
| 2012 Q4 | 9.22 Billion CNY | -12.69% |
| 2012 FY | 9.22 Billion CNY | 2.24% |
| 2012 Q1 | 9.83 Billion CNY | 9.0% |
| 2011 Q2 | 9.43 Billion CNY | 0.4% |
| 2011 Q4 | 9.02 Billion CNY | -3.12% |
| 2011 Q3 | 9.31 Billion CNY | -1.29% |
| 2011 Q1 | 9.39 Billion CNY | 12.24% |
| 2011 FY | 9.02 Billion CNY | 7.77% |
| 2010 FY | 8.37 Billion CNY | 28.48% |
| 2010 Q4 | 8.37 Billion CNY | 8.36% |
| 2010 Q1 | 6.96 Billion CNY | 6.87% |
| 2010 Q3 | 7.72 Billion CNY | 2.25% |
| 2010 Q2 | 7.55 Billion CNY | 8.51% |
| 2009 Q2 | 6.35 Billion CNY | 13.55% |
| 2009 FY | 6.51 Billion CNY | 29.22% |
| 2009 Q4 | 6.51 Billion CNY | 6.25% |
| 2009 Q1 | 5.59 Billion CNY | 10.96% |
| 2009 Q3 | 6.13 Billion CNY | -3.48% |
| 2008 Q1 | 5.16 Billion CNY | 3.28% |
| 2008 Q2 | 5.3 Billion CNY | 2.72% |
| 2008 FY | 5.04 Billion CNY | 0.89% |
| 2008 Q3 | 5.4 Billion CNY | 1.9% |
| 2008 Q4 | 5.04 Billion CNY | -6.68% |
| 2007 Q4 | 4.99 Billion CNY | 1.84% |
| 2007 Q3 | 4.9 Billion CNY | 2.44% |
| 2007 Q2 | 4.79 Billion CNY | 19.61% |
| 2007 Q1 | 4 Billion CNY | 8.66% |
| 2007 FY | 4.99 Billion CNY | 35.58% |
| 2006 FY | 3.68 Billion CNY | 10.77% |
| 2006 Q1 | 3.54 Billion CNY | 6.62% |
| 2006 Q2 | 3.54 Billion CNY | -0.04% |
| 2006 Q3 | 3.61 Billion CNY | 1.88% |
| 2006 Q4 | 3.68 Billion CNY | 2.01% |
| 2005 FY | 3.32 Billion CNY | 6.21% |
| 2005 Q4 | 3.32 Billion CNY | -2.57% |
| 2005 Q3 | 3.41 Billion CNY | 3.86% |
| 2005 Q2 | 3.28 Billion CNY | 1.78% |
| 2005 Q1 | 3.23 Billion CNY | 3.11% |
| 2004 Q1 | 2.6 Billion CNY | -0.82% |
| 2004 Q2 | 2.83 Billion CNY | 8.7% |
| 2004 Q3 | 2.92 Billion CNY | 3.08% |
| 2004 FY | 3.13 Billion CNY | 19.17% |
| 2004 Q4 | 3.13 Billion CNY | 7.24% |
| 2003 Q2 | 2.41 Billion CNY | 26.38% |
| 2003 FY | 2.62 Billion CNY | 44.8% |
| 2003 Q4 | 2.62 Billion CNY | 6.14% |
| 2003 Q3 | 2.47 Billion CNY | 2.76% |
| 2003 Q1 | 1.9 Billion CNY | 5.04% |
| 2002 FY | 1.81 Billion CNY | 55.24% |
| 2002 Q1 | 1.32 Billion CNY | 13.6% |
| 2002 Q2 | 1.36 Billion CNY | 2.85% |
| 2002 Q3 | 1.43 Billion CNY | 5.08% |
| 2002 Q4 | 1.81 Billion CNY | 26.45% |
| 2001 Q4 | 1.16 Billion CNY | 0.0% |
| 2001 Q2 | 1.23 Billion CNY | 0.0% |
| 2001 FY | 1.16 Billion CNY | -4.82% |
| 2000 Q4 | 1.22 Billion CNY | 0.0% |
| 2000 FY | 1.22 Billion CNY | 29.92% |
| 2000 Q2 | 1.21 Billion CNY | 0.0% |
| 1999 Q2 | 919.98 Million CNY | 0.0% |
| 1999 Q4 | 946.17 Million CNY | 0.0% |
| 1999 FY | 946.17 Million CNY | 9.1% |
| 1998 Q2 | 768.24 Million CNY | 0.0% |
| 1998 FY | 867.23 Million CNY | 88.22% |
| 1998 Q4 | 867.23 Million CNY | 0.0% |
| 1997 FY | 460.74 Million CNY | 5.89% |
| 1997 Q4 | 460.74 Million CNY | 0.0% |
| 1997 Q2 | 474.46 Million CNY | 0.0% |
| 1996 Q2 | 431.25 Million CNY | 0.0% |
| 1996 Q4 | 435.11 Million CNY | 0.0% |
| 1996 FY | 435.11 Million CNY | 59.9% |
| 1995 Q4 | 272.11 Million CNY | 0.0% |
| 1995 FY | 272.11 Million CNY | 3.22% |
| 1994 FY | 263.64 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 43.78 Billion CNY | 34.886% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 17.08 Billion CNY | -66.915% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 11.23 Billion CNY | -153.685% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 3.27 Billion CNY | -769.376% |
| Aurora Optoelectronics Co.,Ltd. | 2.17 Billion CNY | -1211.443% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 346.28 Million CNY | -8132.95% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 2.62 Billion CNY | -984.676% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 7.77 Billion CNY | -266.857% |